Kahn SE - Search Results

1

Apoptosis Repressor With Caspase Recruitment Domain Ameliorates Amyloid-Induced β-Cell Apoptosis and JNK Pathway Activation.

Templin AT, Samarasekera T, Meier DT, Hogan MF, Mellati M, Crow MT, Kitsis RN, Zraika S, Hull RL, Kahn SE. Templin AT, et al. Among authors: kahn se. Diabetes. 2017 Oct;66(10):2636-2645. doi: 10.2337/db16-1352. Epub 2017 Jul 20. Diabetes. 2017. PMID: 28729244 Free PMC article.

2

Evidence of cosecretion of islet amyloid polypeptide and insulin by beta-cells.

Kahn SE, D'Alessio DA, Schwartz MW, Fujimoto WY, Ensinck JW, Taborsky GJ Jr, Porte D Jr. Kahn SE, et al. Diabetes. 1990 May;39(5):634-8. doi: 10.2337/diab.39.5.634. Diabetes. 1990. PMID: 2185112

3

Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance.

Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ Jr, Porte D Jr. Kahn SE, et al. Diabetes. 1989 May;38(5):562-8. doi: 10.2337/diab.38.5.562. Diabetes. 1989. PMID: 2653928

4

Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?

Porte D Jr, Kahn SE. Porte D Jr, et al. Among authors: kahn se. Diabetes. 1989 Nov;38(11):1333-6. doi: 10.2337/diab.38.11.1333. Diabetes. 1989. PMID: 2695369 Review.

5

Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse.

D'Alessio DA, Verchere CB, Kahn SE, Hoagland V, Baskin DG, Palmiter RD, Ensinck JW. D'Alessio DA, et al. Among authors: kahn se. Diabetes. 1994 Dec;43(12):1457-61. doi: 10.2337/diab.43.12.1457. Diabetes. 1994. PMID: 7958499

6

Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.

Greenbaum CJ, Kahn SE, Palmer JP. Greenbaum CJ, et al. Among authors: kahn se. Diabetes. 1996 Nov;45(11):1631-4. doi: 10.2337/diab.45.11.1631. Diabetes. 1996. PMID: 8866571 Clinical Trial.

7

Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.

Kahn SE, Halban PA. Kahn SE, et al. Diabetes. 1997 Nov;46(11):1725-32. doi: 10.2337/diab.46.11.1725. Diabetes. 1997. PMID: 9356018

8

Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

Kahn SE, Verchere CB, Andrikopoulos S, Asberry PJ, Leonetti DL, Wahl PW, Boyko EJ, Schwartz RS, Newell-Morris L, Fujimoto WY. Kahn SE, et al. Diabetes. 1998 Apr;47(4):640-5. doi: 10.2337/diabetes.47.4.640. Diabetes. 1998. PMID: 9568698

9

Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.

Kahn SE, Andrikopoulos S, Verchere CB. Kahn SE, et al. Diabetes. 1999 Feb;48(2):241-53. doi: 10.2337/diabetes.48.2.241. Diabetes. 1999. PMID: 10334297 Review.

10

Two novel immortal pancreatic beta-cell lines expressing and secreting human islet amyloid polypeptide do not spontaneously develop islet amyloid.

Andrikopoulos S, Verchere CB, Teague JC, Howell WM, Fujimoto WY, Wight TN, Kahn SE. Andrikopoulos S, et al. Among authors: kahn se. Diabetes. 1999 Oct;48(10):1962-70. doi: 10.2337/diabetes.48.10.1962. Diabetes. 1999. PMID: 10512360

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

569 results

Search Page

Filters